Anxiety disorders and suicidality in the National Comorbidity Survey-Replication

Department of Psychology, Florida State University, P.O. Box 3064301 Tallahassee, FL 32306, United States.
Journal of Psychiatric Research (Impact Factor: 3.96). 02/2009; 43(9):825-9. DOI: 10.1016/j.jpsychires.2008.12.004
Source: PubMed


The current study sought to examine the unique associations between anxiety disorders and suicidality using a large nationally representative sample and controlling for a number of established risk factors for suicide.
Data from the National Comorbidity Survey-Replication were used for analyses. Lifetime diagnostic history and demographics were obtained in this survey through a structured interview. Lifetime suicidal ideation and attempts were also assessed.
Multivariate analyses covarying for psychiatric comorbidity and demographic variables found social anxiety disorder (SAD), posttraumatic stress disorder (PTSD), generalized anxiety disorder (GAD), and panic disorder (PD) to be unique predictors of suicidal ideation, while only SAD, PTSD, and GAD were predictive of suicide attempts. Analyses by gender indicated that each of these four disorders were predictive of suicidal ideation or suicide attempts among women, while only PTSD and PD acted as risk factors among men.
Findings provide further evidence of the negative impact of anxiety disorders, suggest efforts should be made towards their early detection and treatment, and emphasize the importance of suicide risk assessment in treating individuals with anxiety disorders.

1 Follower
8 Reads
    • "Running head: PROJECT REACH OUT 6 diagnosed with PTSD are six times more likely to attempt suicide compared to demographicallymatched controls (Kessler et al., 1999). Depression is also associated with suicidal ideation and suicide attempts (Cougle, Keough, Riccardi, & Sachs-Ericsson, 2009; Nock et al., 2009), and individuals with both PTSD and depression have even higher rates of suicidal ideation than individuals with either PTSD or depression alone (Cougle et al., 2009). Reports of clusters of suicides among firefighters (e.g., Gliha, 2010; Peluso, 2010) only serve to underscore the importance of recognizing behavioral health problems among firefighters and intervening before devastating consequences occur. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The current study examined the efficacy of a newly-developed training program to help firefighters identify fellow firefighters in distress and connect them with behavioral healthcare. This training program—known as Reach Out—incorporates elements of Motivational Interviewing and Community Reinforcement along with basic education about common behavioral health problems. Two active versions of the Reach Out training program (group format vs. video format) were compared to a behavioral health video control condition. One-hundred seventy-two firefighters were randomized to one of the three training conditions. Dependent measures included successful attempts to connect identified firefighters with treatment, intervention effectiveness, and treatment credibility. Firefighters in the video-based Reach Out training condition reported a significant increase in successful interventions and intervention effectiveness from pre-test to the 3-month follow-up compared with the control group. The video-based Reach Out training condition was also rated as significantly more credible than the control condition. While preliminary, these findings suggest that the video-based Reach Out training program may help to increase behavioral health utilization among firefighters. Additional research on this promising new training program is warranted.
    International Journal of Stress Management 05/2015; in press. DOI:10.1037/a0039731 · 1.28 Impact Factor
  • Source
    • "The majority of patients with PTSD also meet criteria for other psychiatric disorders and experience significant functional impairment [2]. Many also attempt suicide [3]. Despite its impact on society, there is only partial understanding of the etiology or pathophysiology of this disorder. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Pharmacologic treatment options for posttraumatic stress disorder (PTSD) are limited in number and effectiveness. Medications currently in use to treat PTSD were originally approved based on their efficacy in other disorders, such as major depression. Substantial research in PTSD suggests that increased activity of corticotropin releasing hormone (CRH)-containing circuits are involved in the pathophysiology of the disease. This Phase II trial aims to evaluate the efficacy of a CRH type 1 receptor (CRHR1) antagonist in the treatment of PTSD. Currently untreated adult women, ages 18 to 65 years, with a primary psychiatric diagnosis of PTSD of at least 3 months’ duration, are being enrolled in a parallel-group, double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of GSK561679, a novel CRHR1 receptor antagonist. GSK561679 (or matching placebo) is prescribed at a fixed dose of 350 mg nightly for six weeks. The primary trial hypothesis is that GSK561679 will reduce symptoms of PTSD, as measured by the Clinician-Administered PTSD Scale (CAPS), significantly more than placebo after six weeks of treatment. Putative biological markers of PTSD which may influence treatment response are measured prior to randomization and after five weeks’ exposure to the study medication, including: fear conditioning and extinction using psychophysiological measures; variants of stress-related genes and gene expression profiles; and indices of HPA axis reactivity. In addition, the impact of PTSD and treatment on neuropsychological performance and functional capacity are assessed at baseline and after the fifth week of study medication. After completion of the six-week double blind treatment period, subjects enter a one-month follow-up period to monitor for sustained response and resolution of any adverse effects. Considerable preclinical and human research supports the hypothesis that alterations in central nervous system CRH neuronal activity are a potential mediator of PTSD symptoms. This study is the first to assess the efficacy of a specific antagonist of a CRH receptor in the treatment of PTSD. Furthermore, the biological and neuropsychological measures included in this trial will substantially inform our understanding of the mechanisms of PTSD. Trial registration Identifier: NCT01018992. Registered 6 November 2009. First patient randomized 14 January 2010.
    Trials 06/2014; 15(1):240. DOI:10.1186/1745-6215-15-240 · 1.73 Impact Factor
  • Source
    • "an independent risk factor for suicide ideation and attempt for both sexes [ 45 , 46 ] . Cougle et al . ( 2009 ) report that for women all four anxiety disorders ( social anxiety disorder , posttraumatic stress disorder , generalized anxiety disorder , panic disorder ) were predictive of suicidality , while for men only posttraumatic stress disorder and panic disorder were identified as risk factors ."
    [Show abstract] [Hide abstract]
    ABSTRACT: Previous research has shown an association between certain personality characteristics and suicidality. Methodological differences including small sample sizes and missing adjustment for possible confounding factors could explain the varying results. The aim of this study was to assess the impact of the Big Five personality dimensions on suicidality in a representative population based sample of adults. Interviews were conducted in a representative German population-based sample (n=2555) in 2011. Personality characteristics were assessed using the Big Five Inventory-10 (BFI-10) and suicide risk was assessed with the Suicidal Behaviors Questionnaire-Revised (SBQ-R). Multivariate logistic regression models were calculated adjusting for depression, anxiety, and various sociodemographic variables. Neuroticism and openness were significantly associated with suicide risk, while extraversion and conscientiousness were found to be protective. Significant sex differences were observed. For males, extraversion and conscientiousness were protective factors. Neuroticism and openness were found to be associated with suicide risk only in females. These associations remained significant after adjusting for covariates. The results highlight the role of personality dimensions as risk factors for suicide-related behaviors. Different personality dimensions are significantly associated with suicide-related behaviors even when adjusting for other known risk factors of suicidality.
    PLoS ONE 10/2013; 8(10):e76646. DOI:10.1371/journal.pone.0076646 · 3.23 Impact Factor
Show more